Skip to main content
Advertisement
Live broadcast

The scientist spoke about the hidden course of Alzheimer's disease

Kodosaki: Good memory may make it harder to detect Alzheimer's disease
0
Photo: IZVESTIA/Polina Violet
Озвучить текст
Select important
On
Off

The brain's ability to compensate for pathological changes allows some people to retain memory and clarity of thinking for a long time, even with signs of Alzheimer's disease. However, external well-being can make timely diagnosis difficult: the disease continues to develop while the results of routine tests remain relatively high. How the cognitive reserve works, why memory disorders in women are sometimes detected later, and how biomarkers can help — in the Izvestia material.

A disease with no noticeable symptoms

Scientists have long observed a discrepancy between the state of brain tissue and memory retention. For example, a 2006 Neurology study examined the brains of 134 deceased participants who were not diagnosed with dementia or mild cognitive impairment during their lifetime.

In 50 people, or about 37%, changes were found that corresponded to neuropathological criteria of moderate or high probability of Alzheimer's disease. At the same time, the results of a brief assessment of cognitive functions before death were close to those of the other participants. These data relate to a specific sample, but show that the severity of the pathology and the visibility of the symptoms may not coincide.

"Coping with a disease is not the same as being protected from it," Kodosaki stressed.

Alzheimer's disease is characterized by pathological changes associated with beta-amyloid and tau proteins. In some people, even with an increased genetic risk, there are relatively few such changes. In others, proteins accumulate, but the brain retains the ability to work for a long time.

This resilience manifests itself in different ways. Sometimes, against the background of pathological accumulations, the loss of nerve cells remains small. In other cases, the cells are damaged and die, but the person continues to remember information well and reason. It is the second option that can make it difficult to detect the disease early.

How the cognitive reserve works

Cognitive reserve refers to the brain's ability to adapt to age-related changes or damage and maintain task performance. Life experience, including education and intellectually challenging work, can contribute to its formation.

A high reserve allows you to retain your abilities for longer, but it does not guarantee the absence of amyloid and tau pathology. For a while, the brain compensates for its effects. When compensation opportunities become insufficient, the deterioration sometimes looks faster: by this point, the changes have already accumulated.

In a study in the Journal of Neurology, Neurosurgery & Psychiatry involving 312 people who were diagnosed with Alzheimer's disease, a higher level of education was associated with a faster decline in some cognitive indicators. However, the results of other studies are ambiguous, so it is impossible to transfer such a pattern to each patient. At the same time, the benefits of the reserve remain: it helps a person to remain independent longer.

Why can violations be detected later in women?

On average, women are better than men at performing some tasks on verbal memory — memorizing words and other speech information. Such tasks are often used in diagnostics. If the initial abilities are high, a decrease may already be occurring, although the result still falls within the generally accepted range.

A 2017 study in the Journal of Alzheimer's Disease compared test results and amyloid load in 994 participants. Under low to moderate stress, women generally performed better than men at delayed word reproduction. At high temperatures, this advantage was no longer observed.

The authors suggested that maintaining higher results at a certain stage may delay the detection of violations. We are talking about a group pattern: the same score in a test does not always mean the same degree of preservation of functions in different people.

Why early diagnosis is important for treatment

The ability to identify the disease at an early stage has become particularly important with the advent of amyloid therapy. In the United States, lecanemab and donanemab are approved for the treatment of Alzheimer's disease with initiation of use at the stage of mild cognitive impairment or mild dementia. Before treatment, it is necessary to confirm the amyloid pathology.

These drugs are able to slow down the clinical deterioration in suitable patients, but do not provide a complete cure. Late diagnosis may limit the possibilities of their appointment within the framework of the studied indications.

However, the detection of a biomarker in a person without symptoms does not in itself mean that such therapy is necessary. The decision requires an assessment of benefit and risk. For example, MRI scans have described changes in lekanemab, including edema and hemorrhages, so treatment requires medical supervision.

When should I see a doctor?

Experts recommend seeking help if memory is deteriorating, changes affect daily activities, or cause concern to loved ones. Not only the test results are important for evaluation, but also the observations of the patient and his family.

Physical and mental activity, communication, adequate sleep, and control of chronic diseases are among the recommendations for maintaining brain health. However, no single habit guarantees the prevention of dementia.

"We still have to figure out what happens in the brains of people who stay healthy, and what exactly changes when this protection begins to weaken," said the researcher.

Переведено сервисом «Яндекс Переводчик»

Live broadcast